Glutathione S-transferases-biomarkers of cancer risk and chemopreventive response

Chemico-Biological Interactions

Volumn 111-112, Issue , 1998, Pages 377-388

  Clapper, Margie L ^a   Szarka, Christine E ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Broccoli; Chemoprevention; Clinical trials; Colon cancer; GST; Oltipraz

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE TRANSFERASE; OLTIPRAZ; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

CANCER RISK; CELL PROTECTION; COLORECTAL CANCER; DETOXIFICATION; ENZYME ACTIVITY; ENZYME DEFICIENCY; HUMAN; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVIEW; ULCERATIVE COLITIS;

BRASSICA OLERACEA VAR. BOTRYTIS; MURINAE;

EID: 0032562479     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(97)00174-9     Document Type: Article

References (41)

1. Seidegård J., Pero R.W., Miller D.G., Beattie E.J. A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis. 7:1986;751-753.
2. Pemble S., Schroeder K.R., Spencer S.R., Meyer D.J., Hallier E., Bolt H.M., Ketterer B., Taylor J.B. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem. J. 300:1994;271-276.
3. Szarka C.E., Grana G., Engstrom P. Chemoprevention of cancer. Ozols R. Current Problems in Cancer. 1994;13-16 Mosby-Year Book, St. Louis, MO.
4. Cooper H.S., Murthy S.N.S. Dysplasia in dextran sulfate sodium (DSS) experimental murine colitis. Gastroenterology. 106:1994;A378.
5. Cooper H.S., Murthy S.N.S., Shah R.S., Sedergran D.J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 69:1993;238-249.
6. Habig W.H., Pabst M.J., Jakoby W.B. Glutathione S-transferases, the first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249:1974;7130-7139.
7. Clapper M.L., Adrian R.H., Murthy S., Kido K., Cooper H.S. Early depletion of detoxification enzyme activity in dextran sulfate sodium-induced mouse colitis. Gastroenterology. 112:1997;A782.
8. Lafuente A., Molina R., Palou J., Castel T., Moral A., Trias M. Phenotype of glutathione S-transferase mu (GSTM1) and susceptibility to malignant melanoma. MMM group (multidisciplinary, malignant, melanoma). Br. J. Cancer. 72:1995;324-326.
9. Bell D.A., Taylor J.A., Paulson D.F., Robertson C.N., Mohler J.L., Lucier G.W. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl. Cancer Inst. 85:1993;1159-1164.
10. Lafuente A., Pujol F., Carretero P., Villa J.P., Cuchi A. Human glutathione S-transferase μ (GSTμ) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett. 68:1993;49-54.
11. Heagerty A.H.M., Fitzgerald D., Smith A., Bowers B., Jones P., Fryer A.A., Zhao L., Alldersea J., Strange R.C. Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumours. Lancet. 343:1994;266-267.
12. Strange R.C., Matharoo B., Faulder G.C., Jones P., Cotton W., Elder J.B., Deakin M. The human glutathione S-transferases: a case-control study of the incidence of the GST1 0 phenotype in patients with adenocarcinoma. Carcinogenesis. 12:1991;25-28.
13. Hertervig E., Nilsson Å., Seidegård J. The expression of glutathione transferase μ in patients with inflammatory bowel disease. Scand. J. Gastroenterol. 29:1994;729-735.
14. Szarka C.E., Pfeiffer G.R., Hum S.T., Everley L.C., Balshem A.M., Moore D.F., Litwin S., Goosenberg E.B., Frucht H., Engstrom P.F., Clapper M.L. Glutathione S-transferase activity and glutathione S-transferase μ expression in subjects with risk for colorectal cancer. Cancer Res. 55:1995;2789-2793.
15. Heckbert S.R., Weiss N.S., Hornung S.K., Eaton D.L., Motulsky A.G. Glutathione S-transferase and epoxide hydrolase activity in human leukocytes in relation to risk of lung cancer and other smoking-related cancers. J. Natl. Cancer Inst. 84:1992;414-422.
16. Peters W.H.M., Kock L., Nagengast F.M., Roelofs H.M.J. Immunodetection with a monoclonal antibody of glutathione S-transferase mu in patients with and without carcinomas. Biochem. Pharmacol. 39:1990;591-597.
17. Zhong S., Wyllie A.H., Barnes D., Wolf C.R., Spurr N.K. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis. 14:1993;1821-1824.
18. Chenevix-Trench G., Young J., Coggan M., Board P. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset. Carcinogenesis. 16:1995;1655-1657.
19. Jaiswal A.K. Antioxidant response element. Biochem. Pharmacol. 48:1994;439-444.
20. Prestera T., Holtzclaw W.D., Zhang Y., Talalay P. Chemical and molecular regulation of enzymes that detoxify carcinogens. Proc. Natl. Acad. Sci. USA. 90:1993;2965-2969.
21. Modan B., Barell V., Lubin F., Modan M., Greenberg R.A., Graham S. Low-fiber intake as an etiologic factor in cancer of the colon. J. Natl. Cancer Inst. 55:1975;15-18.
22. Graham S., Dayal H., Swanson M., Mittelman A., Wilkinson G. Diet in the epidemiology of cancer of the colon and rectum. J. Natl. Cancer Inst. 61:1978;709-714.
23. Wattenberg L.W. Inhibition of carcinogenesis by naturally occurring and synthetic compounds. Kuroda Y., Shankel D.M., Waters M.D. Antimutagenesis and Anticarcinogenesis Mechanisms II. 1990;155-166 Plenum, New York.
24. Boyd J.N., Babish J.G., Stoewsand G.S. Modification by beet and cabbage diets of aflatoxin B1-induced rat plasma α-foetoprotein elevation, hepatic tumorigenesis and mutagenicity of urine. Food Chem. Toxicol. 20:1982;47-52.
25. Ansher S.S., Dolan P., Bueding E. Biochemical effects of dithiolthiones. Food Chem. Toxicol. 24:1986;405-415.
26. Prochaska H.J., Santamaria A.B., Talalay P. Rapid detection of inducers of enzymes that protect against carcinogens. Proc. Natl. Acad. Sci. USA. 89:1992;2394-2398.
27. Bogaards J.J.P., Verhagen H., Willems M.I., van Poppel G., van Bladerin P.J. Consumption of brussels sprouts results in elevated α-class glutathione S-transferase levels in human blood plasma. Carcinogenesis. 15:1994;1073-1075.
28. Sreerama L., Hedge M.W., Sladek N.E. Identification of a class 3 aldehyde dehydrogenase in human saliva and increased levels of this enzyme, glutathione S-transferases and DT-diaphorase in the saliva of subjects who continually ingest large quantities of coffee or broccoli. Clin. Cancer Res. 1:1995;1153-1163.
29. Clapper M.L., Szarka C.E., Pfeiffer G.R., Graham T.A., Balshem A., Litwin S., Goosenberg E.B., Frucht H., Engstrom P.F. Preclinical and clinical evaluation of broccoli supplements as inducers of detoxification enzyme activity. Clin. Cancer Res. 3:1997;25-30.
30. Zhang Y., Talalay P., Cho C., Posner G.H. A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc. Natl. Acad. Sci. USA. 89:1992;2399-2403.
31. Bueding E., Dolan P., Leroy J.P. The antischistosomal activity of oltipraz. Res. Commun. Chem. Pathol. Pharmacol. 37:1982;293-303.
32. M.L. Clapper, Chemopreventive activity of oltipraz, Pharmacol. Ther. 77 (1998) (in press).
33. Kensler T.W., Egner P.A., Trush M.A., Bueding E., Groopman J.D. Modification of aflatoxin B1 binding to DNA in vivo rats fed phenolic antioxidants, ethoxyquin and a dithiolthione. Carcinogenesis. 6:1985;759-763.
34. W.A. Smith, J.W. Freeman, R.C. Gupta, Modulation of dibenz[a,l]pyrene-DNA adduction by chemopreventive agents in the human breast epithelial cell line, Proc. Am. Assoc. Cancer Res., Abstract, 1997, 362.
35. Rao C.V., Tokomo K., Kelloff G., Reddy B.S. Inhibition by dietary oltipraz of experimental intestinal carcinogenesis induced by azoxymethane in male F344 rats. Carcinogenesis. 12:1991;1051-1055.
36. Rao C.V., Rivenson A., Katiwalla M., Kelloff G.J., Reddy B.S. Chemopreventive effect of oltipraz during different stages of experimental colon carcinogenesis induced by azoxymethane in male F344 rats. Cancer Res. 53:1993;2502-2506.
37. Prochaska H.J., Talalay P. Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver. Cancer Res. 48:1988;4776-4782.
38. Kensler T.W., Egner P.A., Dolan P.M., Groopman J.D., Roebuck B.D. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. Cancer Res. 47:1987;4271-4277.
39. Clapper M.L., Everley L.C., Strobel L.A., Townsend A.J., Engstrom P.F. Coordinate induction of glutathione S-transferase α, μ, and π expression in murine liver after a single administration of oltipraz. Mol. Pharmacol. 45:1994;469-474.
40. Egner P.A., Kensler T.W., Prestera T., Talalay P., Libby A.H., Joyner H.H., Curphey T.J. Regulation of phase 2 enzyme induction by oltipraz and other dithiolthiones. Carcinogenesis. 15:1994;177-181.
41. O'Dwyer P.J., Szarka C.E., Yao K.-S., Halbherr T.C., Pfeiffer G.R., Green F., Gallo J.M., Brennan J., Frucht H., Goosenberg E.B., Hamilton T.C., Litwin S., Balshem A.M., Engstrom P.F., Clapper M.L. Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz. J. Clin. Invest. 98:1996;1210-1217.